A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in ...

Source Reference: Manley GT, et al "A new characterisation of acute traumatic brain injury: The NIH-NINDS TBI Classification and Nomenclature Initiative" Lancet Neurol 2025; DOI: 10.1016/S1474 ...

Source Reference: Klompas M "Antibiotic prophylaxis for patients with acute brain injury" Lancet Respir Med 2024; DOI: 10.1016/S2213-2600(24)00006-7.

Here, the research team discovered that mitochondrial fission is pathologically elevated in mouse and human TBI as well, but that it is caused by increased expression of Fis1, rather than Drp1.

Marking a new age in characterization of acute traumatic brain injury: The NINDS TBI classification and nomenclature initiative Peer-Reviewed Publication ...

Scientists at Duke University have developed an ultrafast photoacoustic imaging system capable of capturing the functional and molecular changes that occur in major brain disorders such as stroke ...

A nasal spray developed to combat neuroinflammation has shown promise in treating traumatic brain injury (TBI) in mouse models. The findings were published in Nature Neuroscience and may pave the way ...